ClinicalTrials.gg
RecruitingNCT06922071REMINDER4CareUpdated May 1, 2026

The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities

An interventional study of REMINDER4Care in Dementia Risk Factors, Prevention and Cognitive Health, sponsored by University of Coimbra. Recruiting at 1 site in Portugal. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by University of Coimbra · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Dementia with a site in Portugal — 9 open to participants now, 9 under way, 1 of them phase 3. Dementia · Portugal.

Planned enrollment
16th of 30
100 · median 104
Started
2025
with 5 others
No phase
24 of 34
6 open now
Registered
28th of 34
by date

Among the 34 studies in Dementia with a site in Portugal, this one is the 16th largest by planned enrollment of the 30 interventional ones that give a count, is one of 6 that started in 2025, is one of 24 with no phase, and was the 28th registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

9 of the 34 studies in Dementia with a site in Portugal are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Dementia with a site in Portugal, or all of them as a file.
02

Study summary

Dementia incidence is rising, posing a public health challenge, but 45% of cases can be prevented by addressing modifiable risk factors. Multidomain trials show that lifestyle changes can improve cognitive function and reduce dementia risk (like the FINGER trial). The REMINDER program, a Portuguese-based dementia risk reduction protocol, was developed for community-dwelling older adults aged 55 and above. However, older adults in Residential and Daycare Facilities (RDF) have distinct needs that demand program adaptation to ensure its relevance and effectiveness. In addition, more studies are needed to evaluate the impact of multidomain interventions with older adults in RDF.

To address these challenges, the REMINDER4Care program was developed as a tailored, multidomain intervention to reduce dementia risk. It emphasizes social and cognitive engagement and advances its adaptation and evaluation in Residential and Daycare Facilities (RDF). To assess efficacy, the investigators will perform a Randomized Controlled Trial.

03

Conditions studied

  • Dementia Risk Factors
  • Prevention
  • Cognitive Health

Browse trials for

Keywords

  • Dementia Risk Factors
  • Prevention
  • Health
  • Aging
  • Residential and Daycare Facilities
  • Lifestyle
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 65 years and older
  • RDF users
  • Elementary reading and writing skills

Exclusion criteria

Exclusion Criteria:

  • Have a clinical diagnosis of dementia and/or (MMSE) scores below the cutoff for the presence of dementia (MMSE \< 22-27, depending on education level)
  • Have a psychiatric or neurological condition that impairs cognition in the long term
  • Have sensory and functional deficits that compromise their participation in the neuropsychological assessment and throughout the intervention sessions
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    REMINDER4Care intervention

    In this arm, participants will receive the intervention - REMINDER4Care. REMINDER4Care is a 20-session group program that includes psychoeducation about the brain, social skills training, using cognitive aids, setting personal goals, and practicing mindfulness.

    Other: REMINDER4Care

  • No intervention
    Waiting-list group

    In this arm, participants will be a waiting-list group and receive the REMINDER4Care interventions after the study ends (after the post-interventions).

Interventions

  • OtherREMINDER4Care

    REMINDER4Care was an adapted version of the original REMINDER program, tailored to the characteristics, needs, and interests of older adults in RDF. The REMINDER4Care intervention includes 20 face-to-face group sessions, each approximately 60 to 75 minutes, held twice a week over ten weeks. This program aims to optimize memory, attention, executive function, and emotional regulation while promoting lifestyle habits that protect the aging brain. The sessions include brain health education, cognitive exercises, compensatory memory strategies, training for managing personally relevant goals (with goal setting), and stress management techniques (compassion-based therapies, relaxation methods, and mindfulness). Social support and emotion regulation strategies (like attention management, positive cognitive reappraisal, and reframing speech) were included to address psychosocial risk factors like stress, social isolation, and depression.

06

What researchers measure

Primary outcomes

  1. Screening

    Participants' sociodemographic (e.g., age, marital status, education level) and clinical (presence of medical diagnosis, current medication, sensory issues, mobility deficits, substance use, and hospitalization).

    Time frame: Screening

  2. Screening

    Dementia risk was assessed using the Lifestyle for BRAin health (LIBRA) score, which ranges from -2.1 to 10.6, with higher scores indicating a greater risk of developing dementia.

    Time frame: Screening

  3. Cognitive status

    Global cognition was assessed using Addenbrooke's Cognitive Examination - Revised (ACE-R), a scale with scores ranging from 0 to 100, where higher scores indicate better cognitive functioning.

    Time frame: Screening and 1-week and 3-months post-intervention

  4. Mood status

    Depressive Symptoms: Assessed using the Geriatric Depression Scale (GDS-30), a 30-item scale with scores ranging from 0 to 30, where higher scores indicate greater depressive symptoms.

    Time frame: Screening and 1-week and 3-months post-intervention

  5. Cognitive status

    Processing Speed: Evaluated with the Symbol Search subtest of the WAIS-III, scored by correct responses within a time limit, with higher scores representing faster processing speed.

    Time frame: Baseline and 1-week and 3-months post-intervention

  6. Cognitive status

    Verbal Initiative: Measured with the Verbal Fluency Test (letters M, R, and alternate category), scored by the number of correct words produced, with higher scores indicating greater verbal initiative.

    Time frame: Baseline and 1-week and 3-months post-intervention

  7. Perceived social isolation and loneliness

    Loneliness: Measured with the UCLA Loneliness Scale (UCLA LS-3), the score was 20 to 80, with higher scores reflecting greater perceived loneliness.

    Time frame: Baseline and 1-week and 3-months post-intervention

  8. Perceived social network

    Social Networks: Evaluated using Lubben's Brief Social Network Scale (LSNS-6), scored from 0 to 30, where higher scores indicate a stronger social network.

    Time frame: Baseline and 1-week and 3-months post-intervention

  9. Functionality status

    Functional abilities: This is measured using the IAFAI (Informant Assessment of Functioning in Aging and Intellectual Disabilities).

    Time frame: Baseline and 1-week and 3-months post-intervention

  10. Perceived quality of life

    Psychological Well-Being: Assessed using the EBEP-R is a short version of the Psychological Well-Being Scale. Higher scores on the EBEP-R indicate better psychological well-being.

    Time frame: Baseline and 1-week and 3-months post-intervention

07

Study locations

1 of 1 sites recruiting
  • Faculty of Psychology and Education Sciences
    Coimbra, Portugal 3000-115, Portugal
    Recruiting
    • Catarina L. B. Baptista, PhD student · Contactcatarinallbaptista23@gmail.com · +351 963 031 318
    • Catarina L. B. Baptista, PhD Student · Principal investigator
08

References and documents

Individual participant data

Plan to share: Undecided — Open science plans will involve sharing IPD with other researchers, clearly anonymized, to promote the study's replication. The investigators are still developing the strategy for data sharing and will update as soon as it is defined.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2025 to primary completion in Jul 2025, 2 months.

Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's 2 months is below that.

Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 31, 2025
First posted
Apr 10, 2025
StartActual
May 1, 2025
Primary completionActual
Jul 31, 2025
CompletionEst.
Dec 31, 2026
Last update
May 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06922071
Lead sponsor
University of Coimbra
Collaborators
Fundação para a Ciência e a Tecnologia
Responsible party
Catarina Baptista (Principal Investigator, University of Coimbra) — Principal investigator
First posted
Apr 10, 2025
Start date
May 1, 2025
Primary completion
Jul 31, 2025
Completion
Dec 31, 2026 (estimated)
Last update
May 1, 2026

Study contacts

Catarina L. B. Baptista, PhD Student
Contact
catarinalbbaptista23@gmail.com
+351 963 031 318
Catarina L. B. Baptista, PhD Student
principal investigator · University of Coimbra
Ana Rita E. S. Silva, Doctorate
study chair · University of Coimbra
Margarida P. Lima, Doctorate
study chair · University of Coimbra
Rosa M. Afonso, Doctorate
study chair · University of Beira Interior

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion